Edit
Array Biopharma
http://www.arraybiopharma.com/Last activity: 19.12.2024
Active - Reference to Pfizer Inc.
Chemistry sales & out-sourcing
Location: United States, Colorado, Boulder
Employees: 201-500
Founded date: 1998
Investors 2
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 10
| Date | Title | Description |
| 19.12.2024 | Colorado BioScience Association: Life Sciences Ecosystem Raised $2.15 Billion This Year | The Colorado BioScience Association (CBSA) announced that the state’s life sciences ecosystem raised $2.15 billion in 2024, a 46% increase compared to 2023. Colorado – recognized as the Hub for Health Impact – has brought in nearly $12 bill... |
| 10.12.2024 | Ambrosia Biosciences Announces $25MM Series A Financing, Including Strategic Investment by Merck | Ambrosia Biosciences announces a second closing of its Series A financing. This closing was led by Merck with additional participation from existing investors. This financing will further expand preclinical development operations in our fac... |
| 17.06.2019 | Pfizer to Acquire Array BioPharma, for $11.4 Billion | Pfizer Inc. (NYSE: PFE) is to acquire Array BioPharma Inc. (NASDAQ: ARRY), a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and oth... |
| 17.06.2019 | Pfizer to buy Array BioPharma for $11.4B | Shares of Array were up more than 59 percent premarket on the Nasdaq following the news and opened at $47 per share. Shares of Pfizer were down about 0.1 percent on the New York Stock Exchange. The company currently markets two products, Br... |
| 17.06.2019 | Boulder’s Array BioPharma to be acquired by Pfizer | Boulder’s Array BioPharma Inc. is merging with Pfizer Inc. in an $11.4 billion deal. The merger agreement was announced Monday. Array BioPharma is a commercial stage biopharmaceutical company focused on the discovery, development and commer... |
| 17.06.2019 | The Hot IPO You Might Have Overlooked: Term Sheet | CONSUMERIZE THE ENTERPRISE While we all gave our undivided attention to flashy IPOs like Uber and Lyft, many overlooked the public market debut of cloud-based cybersecurity company CrowdStrike. You’ve probably heard of it without realizing ... |
| 23.07.2013 | Array Shares Climb After Asthma Drug Shows Positive Phase 2 Results | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Array Biopharma’s stock price jumped more than 15 percent this morning, following the company’s announcement that an oral treatment for asthma it is developing showed positive... |
| 12.07.2013 | Mile High Roundup: A Big Biofuel Moves In and New Energy for Wind | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Welcome to the Mile High Roundup, a fortnightly review and recap of some of the interesting things that have happened over the past two weeks in the tech scene in Boulder, Den... |
| 03.07.2013 | Array Starts First Phase 3 Trial, Shifts to Late-Stage Development | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Array Biopharma said Tuesday it has received a $5 million milestone payment from Novartis for beginning Phase 3 testing of a drug it hopes can treat ovarian cancer. The milest... |
| - | Pfizer to buy Array BioPharma for $11.4B | A large pharmaceutical company is spending more than $11 billion to acquire the maker of two drugs used to treat skin cancer. New York-based Pfizer said Monday it would acquire Boulder, Colorado-based Array BioPharma for $11.4 billion, or $... |